Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients
Immunology · 2026
DOI: 10.1111/imm.70185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Hugo Brouque und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes, Grenobl…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Melanoma, Metabolomics, Energy Metabolism. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Etablissement Français du Sang (EFS) AuRA, Ligue Contre le Cancer, Societe Française de Dermatologie et de Pathologie Sexuellement Transmissible.
Abstract (Originalsprache)
Metabolism is critical for immune cell functions. Tumours shape their microenvironment to render it metabolically hostile for infiltrating immune cells. While targeting immunometabolism emerges as a promising way to reinvigorate anticancer immunity, a deeper understanding of the metabolic disturbances of immune cells is needed. Here, we explored how the metabolic status of T cells governs immune skewing from circulating and tumour‐infiltrating CD4 + and CD8 + T cells of melanoma patients at a single‐cell level using the SCENITH method and targeted metabolomics. Circulating and tumour‐infiltrating T cells from patients displayed a decreased mitochondrial dependency associated with an enhanced glycolytic capacity and a skewed metabolic reprogramming upon stimulation. Such metabolic disturbances were linked to the activation status, immune checkpoint profile and functional orientation of T cells, underlining critical connections between T‐cell features and metabolic patterns. Targeted metabolomics within sorted CD4 + /CD8 + T cells identified a decrease in citrulline, cysteine and threonine within all subsets in patients, together with a sharp rise in sterol cholesterol CE(20:2) and ceramide dhCer(d18:0/22:0) within tumour‐infiltrating CD4 + T cells, and in glycerolipid DG(16:0/16:0) within CD8 + T cells in blood and tumour. We further outlined a metabolic‐checkpoint‐based signature composed of six genes coding enzymes/transporters connected to the imbalanced metabolites found within tumour‐infiltrating T cells ( LIPA , DGKA , GLUL , SLC38A1 , SLC7A7 , GCH1 ) that shape patients' clinical outcome. These findings outline the skewed bioenergetic profiles of T cells and depict metabolic checkpoints associated with immune subversion. Harnessing metabolic pathways is promising for developing innovative therapies to restore optimal anti‐tumour responses and improve clinical success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes, Grenoble, France.
- Etablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, France.
- Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes, Univ. Grenoble Alpes, Grenoble, France.
- Platform for Translational Oncometabolomics, Biocampus, CNRS, INSERM, Université de Montpellier, Montpellier, France.
- European Molecular Biology Laboratory, Grenoble, France.
- Medical Unit of Molecular Genetic (Hereditary Diseases and Oncology), Grenoble University Hospital, Grenoble, France.
ORCID-Profile: Stephane Mouret, Sylvain Henry, Florence de Fraipont, Julie Charles, Andrei Turtoi, Philippe Saas, Caroline Aspord
Förderung
- Etablissement Français du Sang (EFS) AuRA
- Ligue Contre le Cancer
- Societe Française de Dermatologie et de Pathologie Sexuellement Transmissible
- GEFLUC
- Fondation Bristol Myers Squibb (BMS)
- Université Grenoble Alpes (UGA)
- Agence Nationale de la Recherche
- Etablissement Français du Sang
Zitieren
APA
Brouque, H., Mahdy, K., Mouret, S., Henry, S., Niveau, C., Cettour-Cave, M., Pelosse, M., de Fraipont, F., Charles, J., Turtoi, A., Saas, P., & Aspord, C. (2026). Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients. Immunology. https://doi.org/10.1111/imm.70185
Vancouver
Brouque H, Mahdy K, Mouret S, Henry S, Niveau C, Cettour-Cave M, et al. Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients. Immunology. 2026. doi:10.1111/imm.70185
BibTeX
@article{Brouque2026,
author = {Brouque, Hugo and Mahdy, Kareem and Mouret, Stephane and Henry, Sylvain and Niveau, Camille and Cettour-Cave, Mélanie and Pelosse, Martin and de Fraipont, Florence and Charles, Julie and Turtoi, Andrei and Saas, Philippe and Aspord, Caroline},
title = {Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70185}
}
EUVIMED